236. Pseudohypoparathyroidism Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 6 /  Drugs : 5 - (DrugBank : 3) / Drug target genes : 20 - Drug target pathways : 28

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Recombinant human somatotropin
   University of Milan
      1995   -   NCT00497484   Italy
Setmelanotide
   Massachusetts General Hospital
      2026   Phase 2   NCT07496463   United States
Theophylline
   Vanderbilt University Medical Center
      2020   Phase 2   NCT04551170   United States
      2018   Phase 2   NCT03029429   United States
      2015   Phase 2   NCT02463409   United States
Theophylline ER
   Jaclyn Tamaroff
      2020   Phase 2   NCT04240821   United States